ADHD in the News 2020-01-23

Will the FDA give the go-ahead to a prescription video game? The wait goes on, as new data come in

In mid-2018, the startup Akili Interactive Labs asked the Food and Drug Administration to let it do something that’s never been done before: market a video game that physicians would prescribe to kids with ADHD. A year and a half later, that green light has yet to materialize.



Vallon Pharmaceuticals Presents Positive Data from Pilot Intranasal Human Abuse Study of Its Investigational Abuse Deterrent Stimulant, ADAIR, at the American Professional Society of ADHD and Related Disorders (APSARD) Annual Meeting

Vallon Pharmaceuticals Inc., a specialty pharmaceutical company focused on the development of novel drugs for CNS disorders, today announced the presentation of positive data from a pilot study assessing human abuse liability for its investigational Abuse Deterrent Amphetamine Immediate Release (ADAIR).



How to Address Mental Health In the Workplace

In a recent survey produced by Woman’s Day, the Good Housekeeping Institute, and One Mind at Work, 80% of respondents said that either they or a loved one had dealt with mental health challenges. However, a whopping 54% said they couldn’t discuss mental health at work without fear of stigma or discrimination—even though 73% felt they should talk about it.



Report guides pediatricians in care of maltreated children, including pharmacotherapy

Children and adolescents who have experienced maltreatment can struggle even after they are physically safe. They might be bothered by memories of traumatic experiences or impacted by secondary adversities common among those who experience maltreatment. Add changes in relationships and social supports (including possible placement in foster care), challenges with development and academics, and an increased risk for medical problems, and it is no surprise that these children and adolescents require expert, trauma-informed pediatric care.



Attention Deficit Hyperactivity Disorder (ADHD) Market 2020 Global Analysis, Opportunities And Forecast to 2025

The U.S. emerged as a major region for the ADHD market due to increased healthcare expenditure incurred on the treatment & diagnosis of the ADHD patients and growth in the number of hospitals & clinics offering EEG biofeedback & dual therapy. The global attention deficit hyperactivity disorder (ADHD) market is expected to grow with increasing pharmaceutical R&D spending, growing healthcare expenditure, accelerating economic growth, unmet treatment needs and mounting occurrence of ADHD.



Scientists reveal ADHD medication’s effect on the brain

Attention-deficit hyperactivity disorder (ADHD) is a neurobiological disorder characterized by symptoms of hyperactivity, inattention and impulsivity. People with the condition are often prescribed a stimulant drug called methylphenidate, which treats these symptoms. However, scientists do not fully understand how the drug works. Now, researchers at the Okinawa Institute of Science and Technology Graduate University (OIST) have identified how certain areas of the human brain respond to methylphenidate.



Video Game Based Digital Therapy Looks Promising in Pediatric ADHD Trial

Akili Interactive announced topline data from an open-label study (STARS-ADHD Adjunctive) of AKL-T01 for the treatment of attention deficit hyperactivity disorder (ADHD) in children with or without use of stimulants. AKL-T01 is an investigational digital therapeutic that delivers a video game based treatment to help drive engagement and compliance in children living with ADHD. It utilizes the Company’s proprietary Selective Stimulus Management engine (SSME) to distribute sensory and motor stimuli to target and activate the prefrontal cortex of the brain.



ADHD, THE MUSIC BUSINESS, AND ME

After spending over twenty-five years in the music business, it was quite a thing for me to be diagnosed with Attention Deficit Hyperactivity Disorder (ADHD) last year. The psychiatrist told me, “You have had this your entire life.”



Mix of stress and air pollution may lead to cognitive difficulties in children

Children with elevated exposure to early life stress in the home and elevated prenatal exposure to air pollution exhibited heightened symptoms of attention and thought problems, according to researchers at Columbia University Mailman School of Public Health and Columbia Psychiatry. Early life stress is common in youth from disadvantaged backgrounds who also often live in areas with greater exposure to air pollution.



Detroit Area Specialists Teach Women How to Thrive with ADHD

Hinsch is in the minority of women with ADHD. She was diagnosed and has learned how to manage the disorder. Many other women remain undiagnosed and struggle without understanding why, says Ann Arbor psychotherapist Sari Solden, who co-wrote A Radical Guide for Women With ADHD (New Harbinger Publications Inc.) with psychologist Michelle Frank. The book hit bookstores last July.



Parenting a child with ADHD: How to develop daily skills to improve communication and reduce frustration

Parenting any child involves highs and lows. When that child has been diagnosed with ADHD, the highs can be higher and the lows even lower.  



Scant evidence that pharmaceutical CBD or medicinal cannabis can reduce symptoms of mental disorders

There “is a notable absence of high-quality evidence” that cannabis has a therapeutic effect in many mental disorders, according to a comprehensive review and meta-analysis of existing research published in The Lancet.